Diclofenac

This classification denotes a cyclooxygenase inhibitor with the molecular formula C14H11Cl2NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 144O8QL0L1, chemically known as 2-((2,6-dichlorophenyl)amino)benzeneacetic acid but generally known as diclofenac, which bears US NIH Compound Identifier 3033. European Medicines Agency schedules Diclofenac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07092MIG. The term DICLOFENAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules diclofenac in its Anatomical Therapeutic Chemical (ATC) Classification. DICLOFENAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule diclofenac under HS 29224995 and SITC 51465. As of Q4 2014, DICLOFENAC remains the US FDA Preferred Term for this commodity. Diclofenac bears US NLM identifiers UMLS ID C0012091 and NCI Concept Code C28985. SMILES: CLC1C(NC2C(CC(=O)O)CCCC2)C(CL)CCC1.